Notice: Prescription Drug List (PDL): Vitamin D
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-30
Data overview
- Formats
- HTML
- File languages
- English, French